Hos patienter med YMDD- variant HBV, udviste 18/ 39 (46%) forbedringer i nekroinflammatorisk aktivitet og 9/ 39 (23%) udviste forværring.
In patients with YMDD variant HBV, 18/ 39 (46%) had improvements in necroinflammatory activity and 9/ 39 (23%) had worsening.